Share

April 18, 2017; 88 (16 Supplement) April 28, 2017

Efficacy of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia: Results of a Long-Term Study (KINECT 3 Extension) (S56.005)

Stewart Factor, Cynthia Comella, Christoph Correll, Grace Liang, Joshua Burke, Christopher O’Brien
First published April 17, 2017,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 88 no. 16 Supplement S56.005
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 17, 2017.
Copyright & Usage: 
© 2017

Author Disclosures

    1. Stewart Factor1,
    2. Cynthia Comella2,
    3. Christoph Correll3,
    4. Grace Liang4,
    5. Joshua Burke4 and
    6. Christopher O’Brien4
  1. Stewart Factor1,
  2. Cynthia Comella2,
  3. Christoph Correll3,
  4. Grace Liang4,
  5. Joshua Burke4 and
  6. Christopher O’Brien4
  1. 1Emory University School of Medicine Atlanta GA United States
  2. 2Rush University Medical Center Chicago IL United States
  3. 3Hofstra Northwell School of Medicine New York NY United States
  4. 4Neurocrine Biosciences, Inc. San Diego CA United States

Article usage

Article usage: April 2017 to October 2023

AbstractFullPdfSource
Apr 20175300Highwire
May 201717100Highwire
Jun 201718700Highwire
Jul 201712700Highwire
Aug 201715600Highwire
Sep 20174200Highwire
Oct 20174000Highwire
Nov 20174400Highwire
Dec 20175300Highwire
Jan 20185000Highwire
Feb 20182500Highwire
Mar 20183700Highwire
Apr 20182700Highwire
May 20182000Highwire
Jun 20183100Highwire
Jul 20183400Highwire
Aug 20183200Highwire
Sep 20184000Highwire
Oct 20183400Highwire
Nov 20182600Highwire
Dec 2018400Highwire
Jan 2019800Highwire
Feb 20192700Highwire
Mar 20191600Highwire
Apr 20191700Highwire
May 20192800Highwire
Jun 20191500Highwire
Jul 2019700Highwire
Aug 2019500Highwire
Sep 2019600Highwire
Oct 20193200Highwire
Nov 2019900Highwire
Dec 20191000Highwire
Jan 20201100Highwire
Feb 20201100Highwire
Mar 20201500Highwire
Apr 2020800Highwire
May 20201000Highwire
Jun 2020800Highwire
Jul 2020300Highwire
Aug 2020200Highwire
Sep 2020400Highwire
Oct 2020700Highwire
Nov 2020500Highwire
Dec 2020400Highwire
Jan 2021500Highwire
Feb 2021400Highwire
Mar 2021700Highwire
Apr 20211200Highwire
May 2021700Highwire
Jun 2021800Highwire
Jul 20211000Highwire
Aug 20211900Highwire
Sep 2021600Highwire
Oct 2021700Highwire
Nov 20211200Highwire
Dec 2021500Highwire
Jan 20222300Highwire
Feb 20222600Highwire
Mar 20221500Highwire
Apr 20222000Highwire
May 20221600Highwire
Jun 20222000Highwire
Jul 20223100Highwire
Aug 20221500Highwire
Sep 20221900Highwire
Oct 20221400Highwire
Nov 20222000Highwire
Dec 20221900Highwire
Jan 2023800Highwire
Feb 2023500Highwire
Mar 2023700Highwire
Apr 20231100Highwire
May 2023500Highwire
Jun 2023600Highwire
Jul 2023900Highwire
Aug 2023100Highwire
Sep 20231600Highwire
Oct 2023400Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me